In cutaneous T-cell Lymphoma knockdown of Bcl-3 decreases the expression of cIAP1 and cIAP2, resulting in reduced cell survival [48]. This evidence concerns the gene BCL3 and primary cutaneous T-cell non-Hodgkin lymphoma.